Assembly Biosciences, Inc
ASMBAssembly Biosciences, Inc. (ASMB) is a biotechnology company focused on developing therapies for viral infections and liver diseases. The company utilizes innovative approaches, including proprietary core platform technologies, to develop treatments for hepatitis B, other chronic viral infections, and microbiome-related conditions. Founded with a focus on advancing fundamental scientific research into therapeutic solutions, Assembly Biosciences aims to address unmet medical needs with its antiviral and microbiome-based therapies.
Company News
Assembly's NeosAI, built on Microsoft Azure AI Foundry, has demonstrated significant time savings and workflow automation for law firms, with advanced natural language processing and enterprise-grade security.
Insiders have been purchasing shares in American Software, Assembly Biosciences, and Tile Shop Holdings, indicating their confidence in the companies' prospects.
– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 –
Here is how Entera Bio Ltd. (ENTX) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.
Here is how ASLAN Pharmaceuticals Ltd. (ASLN) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.
